Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1994-07-22
1999-02-16
Wax, Robert
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
4351723, 4352523, 43525231, 43525233, 43525421, 4353201, 536 235, 930250, 930260, 935 10, 935 69, 935 73, 935 74, C12N 1515, C12N 1570, C12N 1575, C12N 1581
Patent
active
058719563
ABSTRACT:
A synthetic DNA sequence and its genetic equivalents are disclosed which sequences are capable, when used in a recombinant DNA method, of directing production of a serine protease inibitor protein. Recombinant DNA methods for the production of serine protease inhibitor proteins are also disclosed. These methods incorporate either the synthetic DNA sequence of the present invention or natural DNA sequences isolated from human cDNA or genomic libraries.
REFERENCES:
patent: 4394443 (1983-07-01), Weissman et al.
patent: 4511503 (1985-04-01), Olson et al.
patent: 4530901 (1985-07-01), Weissman
patent: 4546082 (1985-10-01), Kurjan et al.
patent: 4595674 (1986-06-01), Tschesche et al.
patent: 4626510 (1986-12-01), Girandi
patent: 4652639 (1987-03-01), Stabinsky
patent: 4672032 (1987-06-01), Slavkin et al.
patent: 4711848 (1987-12-01), Insley et al.
patent: 4720454 (1988-01-01), White et al.
patent: 4760130 (1988-07-01), Thompson et al.
patent: 4788135 (1988-11-01), Davis et al.
patent: 4845076 (1989-07-01), Heinzel et al.
patent: 4923807 (1990-05-01), Webb et al.
patent: 4952512 (1990-08-01), Loskutoff et al.
patent: 5102995 (1992-04-01), Tollefsen et al.
patent: 5109113 (1992-04-01), Caras et al.
patent: 5151438 (1992-09-01), Sham et al.
patent: 5157019 (1992-10-01), Glover et al.
patent: 5215915 (1993-06-01), Tiberi et al.
patent: 5252725 (1993-10-01), Rubin et al.
patent: 5376633 (1994-12-01), Lezdey et al.
patent: 5532215 (1996-07-01), Lezdey et al.
Alberts, B., et al. (1983), "Recombinant DNA Technology," Molecular Biology of the Cell, Garland Publishing, Inc., New York, pp. 185-196.
Anon (1994), "Aids drugs: Beyond access, " The Economist of January 8th 1994, p. 79.
Rice et al., "Regulation of Proteolysis at the Neutrophil-Substrate Interface by Secretory Leukoprotease Inhibitor," Science, 249:178-181 (1990).
Ohlsson et al. (1984), "Localization of antileukoprotease in the parotid and the submandibular salivary glands," Biological Abstracts, 78:ref. No. 90008 and Acta Otolaryngol (Stockh) (1984), 98:147-151.
Eisenberg, S.P., et al., "Location of the Protease-inhibitory Region of Secretory Leukocyte Protease Inhibitor," The Journal of Biological Chemistry, 265:7976-7981 (1990).
Lucey et al. (1990), "Recombinant human secretory leukocyte-protease inhibitor: In vitro properties, and amelioration of human neutrophil elastase-induced emphysema and secretory cell metaplasia in the hamster," J. Lob. Clin. Med., 115/2:224-232.
Birrer et al. (1992), "Intravenous recombinant secretory leukoprotease inhibitor augments antineutrophil elastase defense," Journal of Applied Physiology, 73/1:317-323.
Ohlsson et al. (1986), "Structure, Genomic Organization, and Tissue Distribution of Human Secretory Leukocyte-Protease Inhibitor (SLPI): A Potent Inhibitor of Neutrophil Elastase," Pulmonary Emphysema and Proteolysis, Academic Press, Inc., pp. 307-324.
Darnell et al. (1986), "Molecular Cell Biology," Scientific American Books, Inc., pp. 54-55 and 258-260.
Wong, Y. N., et al. (1994), "A pharmacokinteic evaluation of HIV protease inhibitors, cyclic ureas, in rats and dogs," Biopharmacuetics & Drug Disposition, 15:535-544.
Dorsey, B. D., et al. (1994), "Synthesis and evaluation of pyridyl analogs of L-735,524: Potent HIV-1 portease inhibitors," Bioorganic Medicinal Chemistry Letters, 4:2769-2774.
Rose, J. R., et al. (1994), "Structure-assisted design of nonpeptide human immunodeficiency virus-1 protease inhibitors," American Journal of Respiratory and Critical Care Medicine, 150:S176-S182.
Chen, Z., et al. (1995), "Three-dimensional structure of a mutant HIV-1 protease displaying cross-resistance to all protease inhibitors in clinical trials," The Journal of Biological Chemistry, 270:21433-21436.
Maschera, B., et al. (1995), "Analysis of resistance to human immunodeficiency virus type--protease inhibitors by using matched bacterial expression and proviral infection vectors," Journal of Virology, 69:5431-5436.
Kramps et al. (1990), "Proteinase inhibitor activities of antileukoprotease are represented by its second COOH-terminal domain," Biochimca et Biophysica Acta, 1038/2:178-185.
Bohm et al. (1991), "Purification of a serine-proteinase inhibitor from human articular cartilage," Biochem. J., 274:269-273.
Hirsch, M. S. (1988), "Antiviral Drug Development for the Treatment of Human Immunodeficiency Virus Infections," The American Journal of Medicine, 85:182-185.
Creighton, T. E. (1983), "Proteins: Structures and Molecular Principles," Freeman & Company, NY, pp. 93-94.
Amann et al. (1983), "Vectors bearing a hybrid trp-lac promoter userful for regulated expression of cloned genes in Escherchia coli," Gene, 25:167-178.
Anderson et al. (1983), "Isolation of a genomic clone for bovine pancreatic trypsin inhibitor by using a unique-sequence synthetic DNA probe," Proc. Natl. Acad. Sci. USA, 80:6838-6842.
Botstein et al. (1982), "Principles and Practice of Recombinant DNA Research with Yeast," The Molecular Biology of the Yeast Sacchromyces, 607-636.
Brake et al. (1984), ".alpha.-Factor-directed synthesis and secretion of mature foreign proteins in Saccharomyces cerevisiae," Proc. Natl. Acad. Sci. USA, 81:4642-4646.
Fritz (1988), "Human Mucus Proteinase Inhibitor (Human MPI)," Biol. Chem. Hoppe-Seyler, 369:79-82.
Fritz (1980), "Proteinase inhibitors in severe inflammatory processes (septic shock and experimental endotoxaemia): biochemical, pathophysiological and therapeutic aspects," Protein Degradation in Health and Disease, Ciba Foundation Symposium, 75:351-379.
Ghrayeb et al. (1984), "Secretion cloning vectors in Escherichia coli," The EMBO J., 3:2437-2442.
Kueppers (1971), "Proteinase Inhibitor in Human Tears," Biochem. Biophys. Acta, 229:845-849.
Leicht et al. (1982), "Sequence homology and structural comparison between the chromosomal human a.sub.1 -antitrypsin and chicken ovalbumin genes," Nature, 297:655-659.
Miller et al. (1981), "Synthesis of Biologically Active Proteins by Recombinant DNA Technology," Drug Development Research, 1:435-454.
Ohlsson et al. (1977), "Isolation and Partial Characterization of a Low Molecular Weight Acid Stable Protease Inhibitor from Human Bronchial Secretion," Hoppe-Seyler's Z. Physiol. Chem., 358:583-589.
Schiessler et al., (1976), "Inhibitors of Acrosin and Granulocyte Proteinase from Human Genital Tract Secretions," Hoppe-Seyler's Z. Physiol. Chem. Bd., 357:1251-1260.
Schiessler et al. (1978), "Acid-stable inhibitors of granulocyte neutral proteases in human mucous secretions: biochemistry and possible biological function," Chemical Abstracts, 89:abtr. No. 192866u and Neutral Protease of Human Polymorphonuclear Leukocytes, Urban & Schwarzenberg, Inc. Baltimore--Munich, pp. 195-207 (1978).
Travis et al. (1983), "Human Plasma Proteinase Inhibitors," Ann. Rev. Biochem., 52:655-709.
Wallner et al. (1974), "Characterization of an Acid-Stable Proteinase Inhibitor in Human Cervical Mucus," Hoppe-Seyler's Z. Physiol. Chem. Bd., 355:709-715. Secretory Leukocyte Protease Inhibitor by Saccharomyces Cerevisiae," Bio/Technology, 7(1):55-60.
Smith et al. (1985), "Human bronchial leucocyte proteinase inhibitor," Biochem. Journal, 225:463-472.
Whitson, et al. (1986), "Dissociation of the Lactose Repressor--Operator DNA Complex: Effects of Size and Sequence Context of Operator-Containing DNA," Biochemistry, 25:3845-3852.
Chang, et al. (1986), "Saccharomyces cerevisiae Secretes and Correctly Processes Human Interferon Hybrid Proteins Containing Yeast Invertase Signal Peptides," Molecular and Cellular Biology, 6:1812-1819.
Julius et al. (1984), "Isolation of the Putative Structural Gene for the Lysine-Arginine-Cleaving Endopeptidase Required for Processing of Yeast Prepro-.alpha. -Factor,3" Cell, 37:1075-1089.
Broach, James R. (1983), "Construction of High Copy Yeast Vectors Using 2 .mu.m Circle Sequences," Methods in Enzymology, 101:307-325.
Emr et al. (1983), "An MF.alpha.1-SUC2 (.alpha.-factor-invertase) gene fusion for study of protein localization and gene expression in yeast," Proc. Natl. Acad. Sci. USA, 80:7080-7084.
Derynck et al. (1984), "Human Transforming Growth Factor-.alp
Bandyopadhyay Pradip K.
Eisenberg Stephen P.
Stetler Gary L.
Thompson Robert C.
Amgen Inc.
Moore William W.
Wax Robert
LandOfFree
Recombinant methods for production of serine inhibitors and DNA does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant methods for production of serine inhibitors and DNA , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant methods for production of serine inhibitors and DNA will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2061303